Healthcare provider profile · identity verified

Mark A Quaresima, MD

Family Practice · GANSEVOORT, NY · NPI 1467896480

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	431	115
Omeprazole	Omeprazole	410	107
Atorvastatin Calcium	Atorvastatin Calcium	397	124
Rosuvastatin Calcium	Rosuvastatin Calcium	245	75
Gabapentin	Gabapentin	233	60
Amlodipine Besylate	Amlodipine Besylate	214	61
Albuterol Sulfate Hfa	Albuterol Sulfate	191	73
Metoprolol Succinate	Metoprolol Succinate	189	61
Lisinopril	Lisinopril	171	55
Tamsulosin Hcl	Tamsulosin Hcl	141	39
Losartan Potassium	Losartan Potassium	139	39
Eliquis	Apixaban	130	32
Furosemide	Furosemide	125	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	123	33
Metformin Hcl	Metformin Hcl	119	34
Hydrochlorothiazide	Hydrochlorothiazide	118	40
Alprazolam	Alprazolam	117	33
Simvastatin	Simvastatin	113	34
Potassium Chloride	Potassium Chloride	112	27
Duloxetine Hcl	Duloxetine Hcl	111	25
Montelukast Sodium	Montelukast Sodium	111	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	106	31
Escitalopram Oxalate	Escitalopram Oxalate	105	32
Fluticasone Propionate	Fluticasone Propionate	102	38
Pantoprazole Sodium	Pantoprazole Sodium	99	30
Ozempic	Semaglutide	94	19
Trazodone Hcl	Trazodone Hcl	90	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	24
Sertraline Hcl	Sertraline Hcl	83	21
Tramadol Hcl	Tramadol Hcl	83	31
Metformin Hcl Er	Metformin Hcl	79	27
Famotidine	Famotidine	77	20
Allopurinol	Allopurinol	76	24
Venlafaxine Hcl Er	Venlafaxine Hcl	74	15
Trulicity	Dulaglutide	73	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	17
Clonazepam	Clonazepam	64	14
Diclofenac Sodium	Diclofenac Sodium	64	24
Metoprolol Tartrate	Metoprolol Tartrate	64	24
Prednisone	Prednisone	63	34
Citalopram Hbr	Citalopram Hydrobromide	60	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	60	22
Spironolactone	Spironolactone	58	17
Quetiapine Fumarate	Quetiapine Fumarate	57	15
Ezetimibe	Ezetimibe	56	suppressed
Finasteride	Finasteride	54	16
Hydroxyzine Hcl	Hydroxyzine Hcl	52	13
Mirtazapine	Mirtazapine	52	12
Clopidogrel	Clopidogrel Bisulfate	51	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	51	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	16
Paroxetine Hcl	Paroxetine Hcl	48	13
Mounjaro	Tirzepatide	46	13
Triamcinolone Acetonide	Triamcinolone Acetonide	46	34
Tizanidine Hcl	Tizanidine Hcl	44	11
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Bupropion Xl	Bupropion Hcl	42	12
Pravastatin Sodium	Pravastatin Sodium	42	14
Amitriptyline Hcl	Amitriptyline Hcl	41	11
Fluoxetine Hcl	Fluoxetine Hcl	40	13
Pregabalin	Pregabalin	39	suppressed
Ondansetron Odt	Ondansetron	38	19
Oxybutynin Chloride Er	Oxybutynin Chloride	38	suppressed
Baclofen	Baclofen	37	suppressed
Lansoprazole	Lansoprazole	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	26
Glipizide	Glipizide	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	11
Jardiance	Empagliflozin	31	13
Pentips Pen Needle	Pen Needle, Diabetic	31	suppressed
Meclizine Hcl	Meclizine Hcl	30	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	26
Buspirone Hcl	Buspirone Hcl	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	14
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Torsemide	Torsemide	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Nabumetone	Nabumetone	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Methylprednisolone	Methylprednisolone	25	21
Myrbetriq	Mirabegron	25	suppressed
Nystatin	Nystatin	25	12
Verapamil Er	Verapamil Hcl	25	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Atenolol	Atenolol	22	suppressed
Nitroglycerin	Nitroglycerin	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	18
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Topiramate	Topiramate	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Azithromycin	Azithromycin	17	15
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Aristada	Aripiprazole Lauroxil	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	13
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Lacosamide	Lacosamide	14	suppressed
Methylphenidate Er	Methylphenidate Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Rexulti	Brexpiprazole	13	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Ibu	Ibuprofen	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Abilify Maintena	Aripiprazole	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Levoxyl	Levothyroxine Sodium	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error